Global Health

More from the Series

Blog Post
G7: Make Plans to Share Excess Vaccine Now
January 04, 2021
The reality is that getting back to normal means rapid vaccination of the entire world – to minimize further virus mutations, to enable regular trade and commerce, and to protect those that are unable to be vaccinated for other health reasons.
Blog Post
Looking Back, Looking Ahead, but First, Wishing You a Happy Holiday and New Year
December 23, 2020
From our CGD family to you and yours, we wish you a happy holiday season and a healthier and happier 2021. And, let me offer an enthusiastic farewell to 2020.
Blog Post
The Best of 2020: What We Read While the World Burned Around Us (Research Edition)
December 18, 2020
We’ve picked our favourite papers and articles about development of the year, picking pieces that help us understand the problems we’re working on better and how best to fix them.
Blog Post
Beyond the Money: How IFIs and MDBs Can Better Support Pandemic Recovery in African Low-Income Countries
December 18, 2020
This blog proposes some critical steps—many of which are long overdue—that international financial institutions (IFIs) and multilateral development banks (MDBs) must take if their money is to work more effectively to support African countries recover from the pandemic’s fallout.
Blog Post
Questions on the COVID-19 Vaccine? We've Got Answers
December 17, 2020
At a recent CGD staff presentation of our work into COVID-19 vaccines, our colleagues raised a large number of interesting questions, so, we asked our colleagues to send in their questions on the COVID-19 vaccine portfolio. 
Blog Post
Measuring the Effectiveness of Health Taxes: The Cigarette Tax Scorecard
December 14, 2020
Tobacco taxes are a highly effective instrument to reduce the consumption of tobacco, discourage new young smokers, raise government revenue, and help reduce the social and economic costs of tobacco products consumption, estimated at 8 million premature deaths per year and costing 1.8 percent of glo...
WORKING PAPERS
Malaria Case Management After the Affordable Medicines Facility for Malaria (AMFm): Availability, Quality, and Market Share for ACTs in Kenya’s Private Pharmacies
Daniel Rosen et al.
December 14, 2020
Between 2011 and 2016, the Affordable Medicines Facility-Malaria (AMFm) subsidy program substantially increased access to WHO prequalified artemisinin combination therapies (ACTs) through Africa’s private sector pharmacies and drug-sellers. While the program was rigorously and extensively evaluated,...